139 related articles for article (PubMed ID: 498422)
1. DNA-binding parameters of daunorubicin and doxorubicin in the conditions used for studying the interaction of anthracycline-DNA complexes with cells in vitro.
Schneider YJ; Baurain R; Zenebergh A; Trouet A
Cancer Chemother Pharmacol; 1979; 2(1):7-10. PubMed ID: 498422
[TBL] [Abstract][Full Text] [Related]
2. The interaction of daunorubicin and doxorubicin with DNA and chromatin.
Zunino F; Di Marco A; Zaccara A; Gambetta RA
Biochim Biophys Acta; 1980 Apr; 607(2):206-14. PubMed ID: 7370266
[TBL] [Abstract][Full Text] [Related]
3. Uptake of free and DNA-bound daunorubicin and doxorubicin into human leukemic cells.
Paul C; Peterson C; Gahrton G; Lockner D
Cancer Chemother Pharmacol; 1979; 2(1):49-52. PubMed ID: 498420
[TBL] [Abstract][Full Text] [Related]
4. DNA-binding characteristics of aclarubicin as compared with daunorubicin and doxorubicin.
Ando S; Kamiya K; Yoshimura T; Tsutani H; Ueda T; Uchida M; Nakamura T; Uchino H
Anticancer Res; 1988; 8(3):409-15. PubMed ID: 3164610
[TBL] [Abstract][Full Text] [Related]
5. Adriamycin and daunorubicin bind in a cooperative manner to deoxyribonucleic acid.
Graves DE; Krugh TR
Biochemistry; 1983 Aug; 22(16):3941-7. PubMed ID: 6615810
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the binding of anthracycline derivatives to purified DNA and to cell nuclei.
Frezard F; Garnier-Suillerot A
Biochim Biophys Acta; 1990 Nov; 1036(2):121-7. PubMed ID: 2223830
[TBL] [Abstract][Full Text] [Related]
7. Comparative study in mice of the toxicity, pharmacology, and therapeutic activity of daunorubicin-DNA and doxorubicin-DNA complexes.
Deprez-De Campeneere D; Baurain R; Huybrechts M; Trouet A
Cancer Chemother Pharmacol; 1979; 2(1):25-30. PubMed ID: 498415
[TBL] [Abstract][Full Text] [Related]
8. Interaction of aclarubicin with DNA as compared with daunorubicin and doxorubicin.
Ando S; Sasada M; Uchino H; Kagawa D; Ueda T; Nakamura T
Nihon Gan Chiryo Gakkai Shi; 1986 Dec; 21(10):2343-55. PubMed ID: 3471823
[No Abstract] [Full Text] [Related]
9. Equilibrium binding of daunomycin and adriamycin to calf thymus DNA. Temperature and ionic strength dependence of thermodynamic parameters.
Barcelo F; Martorell J; Gavilanes F; Gonzalez-Ros JM
Biochem Pharmacol; 1988 Jun; 37(11):2133-8. PubMed ID: 3377816
[TBL] [Abstract][Full Text] [Related]
10. Fate of DNA and its complexes with daunorubicin and adriamycin in rat fibroblasts [proceedings].
Noël G; Trouet A
Arch Int Physiol Biochim; 1977 Feb; 85(1):189-9. PubMed ID: 68743
[No Abstract] [Full Text] [Related]
11. Comparison of intracellular drug retention, DNA damage and cytotoxicity of derivatives of doxorubicin and daunorubicin in a human colon adenocarcinoma cell line (LoVo).
Belvedere G; Suarato A; Geroni C; Giuliani FC; D'Incalci M
Biochem Pharmacol; 1989 Nov; 38(21):3713-21. PubMed ID: 2557027
[TBL] [Abstract][Full Text] [Related]
12. Cell cycle related uptake, retention and toxicity of idarubicin, daunorubicin and doxorubicin.
Minderman H; Linssen P; Wessels J; Haanen C
Anticancer Res; 1993; 13(4):1161-5. PubMed ID: 8352539
[TBL] [Abstract][Full Text] [Related]
13. Uptake and retention of adriamycin and daunorubicin by sensitive and anthracycline-resistant sublines of P388 leukemia.
Inaba M; Johnson RK
Biochem Pharmacol; 1978; 27(17):2123-30. PubMed ID: 31880
[No Abstract] [Full Text] [Related]
14. Analysis of binding of daunorubicin and doxorubicin to DNA using computerized curve-fitting procedures.
Bryn SR; Dolch GD
J Pharm Sci; 1978 May; 67(5):688-93. PubMed ID: 641812
[No Abstract] [Full Text] [Related]
15. DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA.
Bodley A; Liu LF; Israel M; Seshadri R; Koseki Y; Giuliani FC; Kirschenbaum S; Silber R; Potmesil M
Cancer Res; 1989 Nov; 49(21):5969-78. PubMed ID: 2551497
[TBL] [Abstract][Full Text] [Related]
16. Interaction of new derivatives of daunorubicin and adriamycin with DNA.
Arlandini E; Vigevani A; Arcamone F
Farmaco Sci; 1977 May; 32(5):315-23. PubMed ID: 862886
[TBL] [Abstract][Full Text] [Related]
17. Fluorinated anthracyclines: interactions with DNA.
Tonkin KC; Boston RC; Brownlee RT; Phillips DR
Invest New Drugs; 1990 Nov; 8(4):355-63. PubMed ID: 2084069
[TBL] [Abstract][Full Text] [Related]
18. Melanin inhibits cytotoxic effects of doxorubicin and daunorubicin in MOLT 4 cells.
Svensson SP; Lindgren S; Powell W; Green H
Pigment Cell Res; 2003 Aug; 16(4):351-4. PubMed ID: 12859618
[TBL] [Abstract][Full Text] [Related]
19. Expression of doxorubicin-daunorubicin resistance genes in different anthracycline-producing mutants of Streptomyces peucetius.
Colombo AL; Solinas MM; Perini G; Biamonti G; Zanella G; Caruso M; Torti F; Filippini S; Inventi-Solari A; Garofano L
J Bacteriol; 1992 Mar; 174(5):1641-6. PubMed ID: 1537806
[TBL] [Abstract][Full Text] [Related]
20. Accumulation of degradation products of doxorubicin and pirarubicin formed in cell culture medium within sensitive and resistant cells.
Fiallo M; Laigle A; Borrel MN; Garnier-Suillerot A
Biochem Pharmacol; 1993 Feb; 45(3):659-65. PubMed ID: 8095138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
